|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:1205-1215
© 2000 The American Association for Thoracic Surgery
SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE |
From the Department of Thoracic and Cardiovascular Surgery,a Department of Biostatistics and Epidemiology,b Department of Cardiology,c The Cleveland Clinic Foundation, Cleveland, Ohio.
Address for reprints: Nicholas G. Smedira, MD, Department of Thoracic and Cardiovascular Surgery, 9500 Euclid Ave, Desk F25, Cleveland, OH 44195 (E-mail: smedirn{at}ccf.org ).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Data
CVIR personnel prospectively abstracted the patients clinical records. These prospective data were supplemented by thorough review of all clinical records and by quantitative echocardiographic review (see below).
The majority of the women had moderately severe (44 [40%]) or severe (47 [43%]) aortic regurgitation, although 18 (17%) had only moderate regurgitation. Pathology of the aortic valve itself was not remarked upon in the records of 33 (30%) patients, and these may represent structurally normal valves. It was stated explicitly that the valve was structurally normal in 58 (53%). In a few the aorta was bicuspid (7 [6%]), prolapsing (6 [6%]), or had restricted motion (without stenosis, 5 [5%]).
The reason for operation was symptomatic aortic regurgitation in 46 (42%), aneurysmal disease in 26 (24%), and the combination of symptomatic regurgitation and aneurysmal disease in 37 (34%) patients. More than half the women (58%) came to operation for aortic regurgitation associated with aneurysmal disease. This was treated by ascending aortic aneurysm repair in 59, either by root replacement (composite graft or allograft, n = 31) or by the interposition graft technique (n = 28). No valve-sparing operations were performed.
The women ranged in age from 18 to 79 years with a median age of 67 years. They weighed between 46 and 115 kg, with 90% weighing less than 81 kg. Their body surface area (BSA) ranged from 1.43 m2 to 2.28 m2, with a median of 1.68 m2. Cardiac and noncardiac comorbidities of these women are described in Appendix Table I.
Echocardiographic measurements
Biplane and multiplane transesophageal echocardiography was performed preoperatively in 106 patients by means of a Hewlett-Packard ultrasonographic system with a 5-MHz biplane or multiplane transesophageal echocardiography transducer. With the aid of a plane orthogonal to the aortic short axis, standard diameter measurements were made at the aortic anulus, sinus of Valsalva, sinotubular junction, mid ascending aorta at the level of the right pulmonary artery, and the proximal descending aorta.
4 The distribution of sizes of each of these structures is given in Appendix Table II.
Because the size of the normal aorta varies according to the size of the person, the measurements were also expressed as centimeters per square meter BSA, the indexed aortic size. For illustration, the distribution of the size of the ascending aorta indexed to body size is presented in Fig 1. In this figure we have also presented for comparison the mean predicted aortic diameter of a size-matched young female population.
5 There is a known age-related increase in size of the aorta that we deliberately did not take into account in making these mean normal predictions because this relation may represent degeneration and not normality.
6 In addition, we have calculated the Z-value for the observed size of the ascending aorta on the basis of these normal sizes, which is also shown in Appendix Table II
. The Z-value is the number of SDs above or below the mean normal value on the basis of the variability of normal young subjects.
6
|
|
Outcome events
The outcomes for this study were (1) death from all causes and (2) an aortic event. Each death was reviewed, and a search was made for death certificates and other medical documents concerning the circumstances of the death. This yielded a minimum number of women dying of reported aortic rupture.
We defined an aortic event as occurring if the patient died of aortic rupture or required an operation on the thoracic aorta after aortic valve repair or replacement to prevent rupture. One woman was reoperated on for a pseudoaneurysm of the left coronary artery after a Bentall operation, and this was not considered an aortic event. Because of the limited number of autopsies performed, the diagnosis of rupture was based on clinical and radiographic results and discussions with families and physicians. An attempt was made to determine the site of aortic rupture from all available data; because of the limitation cited above and the limited number of reoperations, the designated site of the aortic problem is only the likely site and not the definitive site.
Data analysis
Risk-unadjusted analyses
Nonparametric estimates of survival and freedom from aortic rupture or repair were obtained by the method of Kaplan and Meier.
7 A parametric method was used to resolve the number of hazard phases, identify the shape of the hazard function, and estimate its parameters.
8 The duration of the two hazard phases identified in this study was across all time, but the early hazard phase dominated risk over the first year after operation. This was determined analytically from the data and not arbitrarily.
In addition, the magnitude of effect of aortic events on overall survival was estimated by censoring patients at the time of aortic rupture or repair (an aortic event) to obtain survival were aortic events not to occur. This analysis uses the theory of competing risks (multiple decrement tables).
8-11 To accomplish this, at any time after operation, patients were placed in one of three mutually exclusive categories: (1) those still alive without an aortic event (so-called event-free survival), (2) those dying before an aortic event, and (3) those experiencing an aortic event. The common interval used for analysis was the earliest occurrence of death, an aortic event, or end of follow-up.
Multivariable analyses
The potential risk factors (variables) for death, aortic event (aortic rupture or repair), and death before an aortic event were organized for entry into the analyses as shown in Appendix Table III.
For general conduct of the multivariable analyses, exploratory analysis included correlation analysis, stratified life table analyses, and decile risk analysis of ordinal and continuous variables to determine possible transformations of scale (calibration). A directed technique of entry of variables into the multivariable risk factor model was then used.
12 Extensive analysis was made of possible interactions, concentrating specifically on interactions with repair of the aorta. Noninformative imputation of missing values used the mean of values present in the data set; in addition, an indicator variable was created to assess and adjust for possible differences between patients with and without missing values for a variable. The P value criterion for retention of variables in the final model was .1.
Exploration of the influence of risk factors in the parametric multivariable analysis was performed by constructing nomograms representing the solution of the parametric equation for specific supplied values of each factor.
The relationship of indexed size of the ascending aorta to the same variables incorporated into other multivariable analyses, except for other aortic structures, was conducted with the use of multiple linear regression.
Presentation
Regression coefficients are presented plus or minus one SE. We do not present hazard ratios because the hazard functions were not found to be proportionate across time; thus, nonproportional hazards methods were used.
Life tables and parametric estimates of the survivorship and hazard functions are presented with asymmetric confidence limits (CL) equivalent in width to one SE (68%).
| Results |
|---|
|
|
|---|
|
|
Risk factors for death included older age at operation, a history of smoking, a preoperative history of atrial fibrillation, and worse left ventricular dysfunction (Table II). Importantly, concomitant aortic replacement was not associated with increased risk, and specifically use of a composite valve and graft (Bentall operation) or aortic allograft as an aortic root replacement was associated with more favorable late survival. The strength and certainty of these factors differed somewhat for all deaths and for deaths before an aortic event. Each of these risk factors is illustrated by univariable stratified life tables in Appendix Table IV. A relation between the size of aortic structures and overall death was masked by background deaths from various causes and by the aortic repair variable (P > .2).
Aortic rupture or repair (aortic events)
Fifteen women experienced either fatal aortic rupture (n = 13) or underwent emergency operation for prevention of aortic rupture (n = 2). Freedom from an aortic event was 97%, 87%, and 76% at 1, 5, and 10 years of follow-up, respectively. The incidence of an aortic event was constant across time at 2.7% per patient-year (CL, 2.1%-3.5%).
Two risk factors were found for aortic events. Older women were at higher risk (constant hazard coefficient, 0.054 ± 0.030; P = .07), as were women who had not undergone aortic replacement and had a larger ascending aorta ([1/indexed ascending aortic size], 11.6 ± 5.3; P = .03). No patient with an ascending aortic size of less than 3.5 cm experienced an aortic event in this study. However, the strongest association was not with absolute ascending aortic size but with the size of the aorta indexed to the size of the patient. The interrelation of these two factors in women not undergoing aortic replacement at the initial operation is illustrated by the nomogram in Fig 3. The figure illustrates that the older the patient, the more dangerous is a given degree of ascending aortic enlargement.
|
|
Likely site of aortic rupture
In the examination of the evidence for aortic rupture, we attempted to determine the likely site of the rupture on the basis of the available data (Table III). In women who did not have ascending aortic operations, 5 (71%) of 7 ruptures likely occurred in the ascending aorta, 1 (14%) in the descending aorta, and 1 (14%) at an unknown site. In contrast, among women who had undergone ascending aortic operations, 5 (62%) of 8 ruptures likely occurred in the descending aorta, 1 (12%) in the ascending aorta, and 2 (25%) at an unknown site.
|
| Discussion |
|---|
|
|
|---|
In our series most of the valves were morphologically normal, with aortic enlargement the likely cause of the aortic regurgitation. No valve-sparing operations were performed. This reflects the calendar years of the study and perhaps reflects that the surgical focus was primarily on aortic regurgitation and not aortic enlargement.
Aneurysmal changes of the ascending aorta were present in our study in 58% of the patients as defined by the surgeon, yet 38% of the patients not having ascending replacements had aortas that measured 4 cm or greater. This group was at particularly high risk, with 32% experiencing an aortic event, 71% of these being in the ascending aorta. The risk was most strongly associated with size indexed to the patients size and not absolute aortic size.
From our data, 2.4 cm/m2 or greater than 4.0 cm appears to be a reasonable threshold to consider aortic replacement in this group of patients. It is important to remember that the risk of aortic events is also related to age and is increased at similar aortic sizes in older patients. The risks of replacement will need to be balanced against the risks of future events.
General discussion
Why is there such heterogeneity in the threshold for aortic replacement in this series? One reason may have been concern about the increased risks of adding an aortic replacement to the valve procedure. More likely is the general lack of consensus in the surgical literature of the appropriate size for aortic replacement in aneurysmal disease. For example, the Ad Hoc Committee of Reporting Standards, Society for Vascular Surgery, has recommended defining the presence of an aneurysm when it is 50% larger than the normal size.
13 The normal size of the ascending aorta in this report was based on a 1949 radiographic study of aortic dimension. More recent literature has recommended replacement when the ascending aorta is larger than 5.5 to 6.0 cm.
6,14 Depending on the criteria used, less than 25% to over 75% of the patients in this study would have had aortic replacement. In these publications there was no recommendation to adjust dimension criteria to the patients size, age, sex, or aortic pathology during valve or coronary procedures.
In a similar series from Japan of 86 patients with severe aortic regurgitation Natsuaki and colleagues
15 found a 59% 10-year survival and 75% freedom from aortic events in patients with ascending aortas of greater than 4.0 cm at the time of valve replacement. Aortoplasty appeared to be protective. In this study the average BSA was 1.6 m2. In the group with the aortic dimension/BSA ratio of less than 2.0 cm/m2, there was one late death and no complications compared with the group with a ratio of greater than 2.9 in which there were 10 aortic complications and 9 late deaths. Thus, the ratio for aortic replacement of 2.4 cm/m2 as determined in our article coincides with the 2.5 cm/m2 (4.0 cm) as recommended in Natsuakis article.
Is the risk of rupture found in women only a size issue, or is there a sex-based predilection to aortic enlargement, especially with aging? A recent study highlights sex differences in thoracic aortic aneurysm occurrence and rupture risk. A population-based cohort study from Olmsted County, Minnesota, found that the incidence of thoracic aortic aneurysm was the same for men and women, but women had similar sized aneurysms (4.9 cm on average) much later in life: 63 years for men versus 76 years for women. Of the ruptures that occurred, 79% were in women, with a 5-year rupture risk of 33% versus 9% for men.
16 The reason for this increased rupture risk associated with older age in women is unknown. One possible explanation is that the standard size criteria for intervening may not be neutral to sex, and if indexed to BSA, womens aortic sizes would reach the threshold for intervention at a smaller absolute size. We now know from a recently published study that the aortic enlargement associated with bicuspid valve disease is related to severe degenerative changes in the aortic wall and not the valve disease.
17 Baron and Galea
18 have found that the media/ intima ratio of collagen and elastin content of the carotid artery decreases in postmenopausal women, suggesting that wall structure and strength may deteriorate with age. How these findings, aging, and the hormonal state of postmenopausal women affect aortic wall structure and composition requires further study.
Limitations
The study is retrospective in nature, and the size criteria for defining aneurysm disease were not uniform. This fact, however, allowed us to investigate the outcome of patients who did and did not have aortic replacement yet had similar sized ascending aortas. Determination of the exact cause of death was problematic with the limited number of autopsies. Detailed interviews with patients families and physicians strongly support the designation of aortic rupture as the cause of death but cannot prove it. Similarly, the site of rupture is inferred from the clinical data and is labeled as a likely site of rupture in the article to highlight this limitation. Without a direct comparison with a similar group of men, the effect of sex on outcome remains unclear.
Clinical inferences
The data suggest that our current size criteria for aortic replacement are too conservative in women. As aortic operation has become increasingly refined and safe, liberalizing the size criteria for replacement is appropriate and potentially life-saving. Cohn has recommended that during aortic valve replacement for aortic stenosis, moderately enlarged (4.5 cm) aortas should be replaced.
19 Because dimension is the most common criteria used, we advocate normalizing to BSA and using 2.4 to 2.5 cm/m2 as the threshold to consider intervention when operating on aortic valve pathology. Recognizing the abnormal aortic wall pathology in patients with a bicuspid aortic valve supports an aggressive approach in these patients. Age appears to be an important risk factor for future events. Whether sex itself is a risk and whether intervention is required in an asymptomatic woman with a normally functioning aortic valve but an aorta around 2.4 cm/m2 requires further study. Finally, postoperative radiographic surveillance of the remaining aorta is imperative as ascending aortic replacement reduces but does not eliminate the risk of future aortic events.
| Appendix: Discussion |
|---|
|
|
|---|
In patients who had an ascending aortic diameter of more than 5.0 cm and did not have aortic replacement, 3 (60%) of 5 patients had ascending aortic rupture. If the ascending aortic diameter was between 4.0 and 5.0 cm and not replaced, 2 (14%) of 14 had ascending aortic rupture. If the aortic diameter was less than 4.0 cm and not replaced, none of the patients experienced a rupture. Interestingly, if the aortic diameter was greater than 4.0 cm and was replaced, 2 (3%) of 58 patients still had ascending aortic rupture. Clearly, your data show that the risk of ascending aortic rupture after aortic valve replacement rises with increasing ascending aortic diameter and is decreased by replacement of the dilated aorta but not eliminated.
I agree with your conclusions that the threshold for aortic replacement should be lower for patients expected to have a normally smaller aorta, which in most patients are the small, young, or female patients. The threshold for ascending aortic replacement should also be lower for patients in whom the chest is opened for other cardiac procedures in which the dilated aorta may not handle manipulation and suturing very well, leading to trouble. Thus, it is convenient for both the patient and the surgeon to replace the dilated aorta to prevent this later trouble. I also agree strongly that any patient with a history of a dilated aorta, whether repaired or not, should have careful follow-up to watch for progression of aortic disease and allow elective repair, and this follow-up should include both the thoracic and abdominal aorta.
My questions are as follows. First, how many of the patients in this study had the diagnosis of aortic rupture confirmed by autopsy versus by clinical or radiographic signs versus by merely having sudden death? Two, why was there rupture in the ascending aorta despite previous ascending aortic replacement, and how can this be prevented? Three, is the diameter of the ascending aorta that you currently use as your threshold for ascending aortic replacement in women after aortic valve replacement, which you have described at the end here, different for patients with aortic valve stenosis versus regurgitation, and is it different for men?
|
|
|
In answer to your second question, some of the ascending aortic ruptures were late technical complications. For example, one patient died of a ruptured pseudoaneurysm. We found that women undergoing isolated valve replacement experienced early deaths, being primarily from ascending aortic rupture, whereas those undergoing an aortic operation experienced later deaths, mainly in the descending aorta. We currently do not have enough information on the preoperative aortic pathology in the cause of aortic rupture to identify a mechanism for these findings. However, we believe that the ascending aorta should be considered for replacement at the time of the operation, and the descending thoracic aorta needs to be monitored because of incomplete protection against future events.
|
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
P. E. Falcoz, S. Chocron, F. Laluc, M. Puyraveau, D. Kaili, M. Mercier, and J. P. Etievent Gender analysis after elective open heart surgery: a two-year comparative study of quality of life. Ann. Thorac. Surg., May 1, 2006; 81(5): 1637 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hirose, L. G. Svensson, B. W. Lytle, E. H. Blackstone, J. Rajeswaran, and D. M. Cosgrove Aortic Dissection After Previous Cardiovascular Surgery Ann. Thorac. Surg., December 1, 2004; 78(6): 2099 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Ferrari, H R Figulla, M Schlosser, I Tenner, I Frerichs, C Damm, V Guyenot, G S Werner, and G Hellige Transarterial aortic valve replacement with a self expanding stent in pigs Heart, November 1, 2004; 90(11): 1326 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Lewis, T. J. Jones, A. M. Ranasinghe, J. R. Lewis, and R. S. Bonser Homograft aortic root with prosthetic extension as a treatment for aneurysm of the proximal aorta in elderly patients J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 573 - 575. [Full Text] [PDF] |
||||
![]() |
P. P. Urbanski, M. Wagner, M. Zacher, and R. W. Hacker Aortic root replacement versus aortic valve replacement: a case-match study Ann. Thorac. Surg., July 1, 2001; 72(1): 28 - 32. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |